Pricing for childhood vaccines is referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

GlaxoSmithKline Financial has been awarded a Texas state contract (HHSTX-6-0000390733) for vaccine and biological products, with pricing referenced to the Centers for Disease Control and Prevention (CDC) Federal Contract Number 75D30125D00198. The contract covers multiple immunological and medical product categories, including immunomodulating drugs, hyaluronic acid derivatives, diphtheria/tetanus/pertussis vaccines, tolvaptan, and thymalfasin, as categorized by UNSPSC and NIGP codes.

The contract, dated November 26, 2025, appears to be focused on providing childhood vaccines and related pharmaceutical products to the state of Texas. The specific contract details such as annual value, total contract amount, and cumulative value were not specified in the source document. The procurement is classified under the NIGP code 26980 for Serums, Toxoids, and Vaccines, indicating a public health-oriented procurement designed to support vaccination and immunization programs within the state's healthcare infrastructure.